ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Current and Future Treatment of Mitral and Tricuspid Valve Disease
Martin R, Borger M, Adams D, Bapat VN, Alfieri OR. Current and Future Treatment of Mitral and Tricuspid Valve Disease. April 2018. doi:10.25373/ctsnet.6022511.
The Current State of the Treatment of Mitral and Tricuspid Valve Disease
Filmed at the 2017 EACTS Annual Meeting in Vienna, Austria, Randy Martin moderates a discussion on the current exciting time in the treatment of degenerative and functional mitral disease and tricuspid repair. Dr Martin is joined by Michael Borger, David Adams, Vinay Bapat, and Octavio Alfieri.
The Future Treatment of Mitral and Tricuspid Valve Disease
The treatment of mitral and tricuspid disease is rapidly advancing to include transcatheter replacement and repair. Randy Martin discusses and debates the evolution and future of these innovative therapies with Michael Borger, David Adams, Vinay Bapat, and Octavio Alfieri.
For additional educational resources, please register at Medtronic Mitral Academy.
These presentations are brought to you with the generous support of:
Printer-friendly
